Stockreport

IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF FDA's marketing authorization for ProSense® for low-risk breast cancer received following the TME Fall Summit—Marke [Read more]